Proxima
Proxima (Proxima Bio) is a preclinical biotechnology company making protein interactions programmable through an integrated discovery platform that combines artificial intelligence, machine learning, and structural proteomics. Building on a proprietary atlas of protein cross-linking data, Proxima trains models that design proximity modulators - Inducers, Modulators, and Blockers - small-molecule therapeutics that induce or block protein-protein complexes to address cancer, autoimmune disorders, and other hard-to-treat diseases. The company is backed by DCVC and collaborates with major pharmaceutical firms. It is listed in the API Evangelist network as a company profile; as of this pass Proxima publishes no public developer API, SDK, or developer portal.
Proxima is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Machine-Learning.
Proxima’s developer surface includes engineering blog and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 3
The organization behind the API